Prochlorperazine and Xeloda drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 203 people who take Prochlorperazine and Xeloda. Common interactions include osteonecrosis of jaw among females, and constipation among males.
The phase IV clinical study analyzes what interactions people who take Prochlorperazine and Xeloda have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
203 people who take Prochlorperazine and Xeloda together, and have interactions are studied.
What is Prochlorperazine?
Prochlorperazine has active ingredients of prochlorperazine. It is used in nausea. Currently, eHealthMe is studying from 12,565 Prochlorperazine users.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is used in colon cancer. Currently, eHealthMe is studying from 46,081 Xeloda users.
Number of Prochlorperazine and Xeloda reports submitted per year:
Prochlorperazine and Xeloda drug interactions by gender *:
Prochlorperazine and Xeloda drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Prochlorperazine and Xeloda?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
Related studies
Drug side effects by duration, gender and age:
- Prochlorperazine side effects (12,565 reports)
- Xeloda side effects (46,081 reports)
Common Prochlorperazine drug interactions:
- Prochlorperazine and Ondansetron: 3,164 reports
- Prochlorperazine and Lorazepam: 2,021 reports
- Prochlorperazine and Dexamethasone: 1,917 reports
- Prochlorperazine and Loraz: 1,436 reports
- Prochlorperazine and Prednisone: 1,413 reports
- Prochlorperazine and Oxycodone: 1,382 reports
- Prochlorperazine and Gabapentin: 1,287 reports
- Prochlorperazine and Acetaminophen: 1,275 reports
- Prochlorperazine and Omeprazole: 1,261 reports
- Prochlorperazine and Furosemide: 1,231 reports
Browse interactions between Prochlorperazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Xeloda drug interactions:
- Xeloda and Avastin: 5,721 reports
- Xeloda and Oxaliplatin: 4,725 reports
- Xeloda and Tykerb: 4,142 reports
- Xeloda and Herceptin: 3,133 reports
- Xeloda and Zometa: 2,520 reports
- Xeloda and Fluorouracil: 1,965 reports
- Xeloda and Taxotere: 1,838 reports
- Xeloda and Cisplatin: 1,597 reports
- Xeloda and Taxol: 1,485 reports
- Xeloda and Zofran: 1,189 reports
Browse interactions between Xeloda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on prochlorperazine and capecitabine (the active ingredients of Prochlorperazine and Xeloda, respectively), and Prochlorperazine and Xeloda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Prochlorperazine and Xeloda.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Neurontin and Spinal Cord Compression - 3 seconds ago
- Protopic and L-Lysine drug interaction - 29 seconds ago
- Coumadin and Fall - 40 seconds ago
- Digoxin and Lucentis drug interaction - a minute ago
- Xanax and Vertebral Wedging - a minute ago
- Sonata and Urinary Tract Infection - a minute ago
- Zocor and Delirium - a minute ago
- Aciphex and Skin Abscess - a minute ago
- Eliquis and Barrett'S Oesophagus - a minute ago
- Nuvaring and Haematuria - a minute ago